U.S. District Court Grants Stay in Case Between SenoRx (SENO) and Hologic (HOLX)
More News related to HOLX
- Hologic to Present at NASDAQ OMX 23rd Investor Program in London
- Xenomics, Inc. and Its Subsidiary TrovaGene, Inc. Announce HPV Patent Filing Based on Transrenal DNA Technology
- After-Hours Movers 11/09: SGK, PCLN, SQNM Higher; MBI, SDTH, UTK, TOPS, CPST, BTN, FLR Lower
- Conceptus(R) to Continue Patent Infringement Suit against Adiana(R) Permanent Contraception System
- Hologic (HOLX) Posts Q3 adj.-EPS of $0.28, Tops by 1c; Guides Q110 EPS
More News related to SENO
- SenoRx Announces Poster Presentation on Interim Results of the First 100 Patients in its Contura(TM) MLB Registry Study Delivered at American Society for Radiology and Oncology (ASTRO)
- After-Hours Movers 11/03: QLTY, PACR, BGCP, TESO Higher; STEC, TRLG, CLRT, CRL, MYGN Lower
- SENORX (SENO) Tops Q3 EPS by 13c; Guides Revs
- SenoRx Continues to Generate Positive Cashflow in the Third Quarter With Ongoing Revenue Growth and Record Gross Margin
- Trading Radar for 11/03: UBS (UBS), Yamana Gold (AUY), Archer-Daniels (ADM), Royal Caribbean (RCL), Marathon (MRO) Report
More News related to Corporate News
- S&P Announces Changes to US Index: CMN for NTG, CVGW for STSA
- Kinross (KGC) Enters Agreement for $125M Letter of Credit Facility
- Endo Pharma (ENDP) Announces Settlement with LecTec Over Outstanding Patent Litigation
- Trubion Pharma (TRBN) Announces Two Presentations of TRU-016 Product at 2009 ASH Meeting
- S&P Revises Outlook on Sirius XM (SIRI) from Stable to Positive
SenoRx (Nasdaq: SENO) announced that the United States District Court for the Northern District of California has granted a joint request by Hologic (Nasdaq: HOLX) and SenoRx to stay all proceedings in the case currently pending between the parties, including the Markman claims construction hearing (previously scheduled for June 25, 2008) and trial (previously scheduled to begin on July 14, 2008), for at least sixty days in order to provide the parties time to discuss possible resolution of the matter.
SenoRx, Inc. is a medical device company focused on developing, manufacturing and selling minimally invasive medical devices for the diagnosis of breast cancer.
Related Categories
Corporate NewsStocks Mentioned
-0.02Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
